NIH-funded research R01 grant

How breast cancer and its treatment affect long-term aging and physical function

Official title: Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment

Funded at Kaiser Foundation Research Institute · NIH-11180970 · Data updated 2026-11-12

This project looks at whether breast cancer and its treatments lead to faster biological aging and physical decline in older women who survived breast cancer.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionKaiser Foundation Research Institute
NIH-funded
Lab location1 site (Oakland, UNITED STATES)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2025
Award (this year)$667,754
NIH project number5R01CA283839-03
Project IDNIH-11180970 on NIH RePORTER

Who could benefit from this research

Could help

Older post-menopausal women with a history of invasive breast cancer who received cancer treatment, particularly those enrolled in the Women's Health Initiative or similar long-term studies.

Less likely to help

Men, younger women, and people without a history of breast cancer are unlikely to directly benefit from this study's results.

What this research studies

If you are an older woman who had breast cancer, this research combines decades of clinical visits, questionnaires, and lab measures from women in the Women's Health Initiative to follow how bodies change over time. Researchers will compare survivors to women without cancer and track frailty, physical function, and molecular signs of aging in blood, including epigenetic clocks. They will also examine whether different treatment types and intensity are linked to faster aging or greater functional decline. The work uses existing long-term data to understand real-world survivorship rather than testing new treatments.

Why it matters

Potential benefit: If successful, this work could help doctors identify survivors at higher risk of early aging and tailor follow-up care to prevent or slow functional decline.

How similar studies have gone: Animal studies and smaller human studies link cancer treatments to molecular signs of aging, but long-term population-level evidence on survivors' aging trajectories is limited, so this approach is relatively novel at scale.

Where this research is happening

  • Kaiser Foundation Research Institute
    Oakland, United States
    Active

Researchers

  • Principal investigator: Feliciano, Elizabeth Marjorie Cespedes — Kaiser Foundation Research Institute
  • Study coordinator: Feliciano, Elizabeth Marjorie Cespedes

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.